AGC Biologics

In a setback for the Japanese bioventure, AnGes, Inc. has discontinued a government-supported R&D project for an injected DNA plasmid vaccine for the original Wuhan strain of COVID-19. While the Osa

The US FDA’s high-profile approval of a broad, breakthrough-designated heart failure indication for Eli Lilly and Company / Boehringer Ingelheim GmbH ’s Jardiance was a ray of sunshine in a week domi

Xbrane Biopharma AB has moved quickly from the landmark filing of its proposed biosimilar to Lucentis (ranibizumab) in Europe, signing a manufacturing agreement with Danish contract development and m

Provention Bio, Inc. is making some headway in its efforts to unblock the regulatory passage of its potential immunotherapy, teplizumab, following receipt in July of a complete response letter, and p